Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances

Nathaniel Reichek1

  • 1From the Research Department and the Cardiac Imaging Program, St. Francis Hospital-the Heart Center and Stony Brook University, New York, USA.

Insights

Cardiac MRI (CMR) reveals new findings in hypertrophic cardiomyopathy (HCM). Advanced CMR techniques help risk-stratify patients and identify novel phenotypes, improving diagnosis and prognosis.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
  • Accurate risk stratification and understanding of HCM phenotypes are crucial for patient management.

Purpose of the Study:

  • To detail novel cardiac magnetic resonance (CMR) findings related to cardiac structure and myocardial composition in HCM.
  • To explore the role of advanced CMR techniques in HCM evaluation.

Main Methods:

  • Quantitative CMR assessment of myocardial fibrosis (replacement and interstitial).
  • Analysis of cardiac structure, including left ventricular hypertrophy (LVH) distribution and severity.
  • Identification of associated abnormalities like myocardial noncompaction and mitral valve apparatus issues.

Main Results:

  • Quantitative CMR assessment of fibrosis aids in risk stratification for adverse outcomes in HCM patients.
  • Global LVH is associated with poorer outcomes, while a spiral hypertrophy pattern suggests a better prognosis.
  • New CMR phenotypes, including myocardial noncompaction and abnormalities in relatives of HCM probands, are identified.

Conclusions:

  • CMR provides valuable structural insights, including hypertrophy and fibrosis patterns, augmenting clinical HCM evaluation.
  • Emerging CMR methods offer potential for detecting myocardial fiber disarray and altered stiffness, enhancing understanding of HCM pathophysiology and outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
671
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
472
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
834